CN1795387A - 生物液体的蛋白质组分析 - Google Patents

生物液体的蛋白质组分析 Download PDF

Info

Publication number
CN1795387A
CN1795387A CN200480014441.1A CN200480014441A CN1795387A CN 1795387 A CN1795387 A CN 1795387A CN 200480014441 A CN200480014441 A CN 200480014441A CN 1795387 A CN1795387 A CN 1795387A
Authority
CN
China
Prior art keywords
protein
proteomic map
albumen
proteomic
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200480014441.1A
Other languages
English (en)
Chinese (zh)
Inventor
罗恩·罗森菲尔德
斯里·纳加拉
迈克·格雷维特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteogenix Inc
Original Assignee
Proteogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteogenix Inc filed Critical Proteogenix Inc
Publication of CN1795387A publication Critical patent/CN1795387A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN200480014441.1A 2003-03-25 2004-03-23 生物液体的蛋白质组分析 Pending CN1795387A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/400,005 US7191068B2 (en) 2003-03-25 2003-03-25 Proteomic analysis of biological fluids
US10/400,005 2003-03-25

Publications (1)

Publication Number Publication Date
CN1795387A true CN1795387A (zh) 2006-06-28

Family

ID=33096805

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200480014441.1A Pending CN1795387A (zh) 2003-03-25 2004-03-23 生物液体的蛋白质组分析

Country Status (12)

Country Link
US (3) US7191068B2 (https=)
EP (2) EP1618388B1 (https=)
JP (2) JP2006524331A (https=)
CN (1) CN1795387A (https=)
AT (1) ATE423322T1 (https=)
AU (2) AU2004225527B2 (https=)
CA (1) CA2560972A1 (https=)
DE (1) DE602004019511D1 (https=)
DK (1) DK1618388T3 (https=)
ES (1) ES2322593T3 (https=)
MX (1) MXPA05010325A (https=)
WO (1) WO2004088324A2 (https=)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102426243A (zh) * 2011-11-17 2012-04-25 成都创宜生物科技有限公司 以Adipsin为检测指标的子痫前期检测试剂盒及制备方法
CN103415769A (zh) * 2010-12-06 2013-11-27 普罗诺塔股份有限公司 用于妊娠性高血压疾病的生物标志物和参数
CN105372414A (zh) * 2015-10-09 2016-03-02 成都大熊猫繁育研究基地 大熊猫乳汁中关键因子的分析方法
CN105452868A (zh) * 2013-03-22 2016-03-30 曼普诊断有限公司 产前筛选
CN107850604A (zh) * 2015-05-12 2018-03-27 生物梅里埃公司 收入重症监护病房的患者发生播散性感染的风险预测
CN108450003A (zh) * 2015-06-19 2018-08-24 赛拉预测公司 用于预测早产的生物标志物对
CN110366597A (zh) * 2016-12-20 2019-10-22 善威生物私人有限公司 用蛋白酶抑制剂进行血液图谱分析
CN113092771A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-1B-糖蛋白及其多肽片段在过敏性疾病中的应用
CN113092773A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-胰蛋白酶抑制剂重链H4及其多肽片段在过敏性疾病中的应用
WO2022027808A1 (zh) * 2020-08-05 2022-02-10 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用
CN120233090A (zh) * 2025-03-28 2025-07-01 中日友好医院(中日友好临床医学研究所) 一组尿蛋白标志物及其在制备非小细胞肺癌预后预测产品中的应用

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511790A (ja) * 2002-11-14 2006-04-06 サイファージェン バイオシステムズ インコーポレイテッド 羊膜内炎症のためのバイオマーカー
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
GB0313828D0 (en) 2003-06-16 2003-07-23 Owen Smith Brian D O Salivary urate for diagnosis of pre-eclampsia
BRPI0418980A (pt) * 2003-08-21 2007-12-11 Univ Mcgill método e aparelho para analisar fluido amniótico
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
WO2006076025A2 (en) * 2004-05-14 2006-07-20 Amaox, Inc. Immune cell biosensors and methods of using same
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
EP2848942B1 (en) 2004-07-14 2017-03-08 The Regents of The University of California Biomarkers for early detection of ovarian cancer
US7670792B2 (en) * 2004-07-14 2010-03-02 The Regents Of The University Of California Biomarkers for early detection of ovarian cancer
US20060094039A1 (en) * 2004-09-20 2006-05-04 Ron Rosenfeld Diagnosis of fetal aneuploidy
DE602005023216D1 (de) * 2004-12-15 2010-10-07 Beth Israel Hospital Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
DE602006018578D1 (de) 2005-01-28 2011-01-13 Childrens Medical Center Diagnose- und prognoseverfahren von blasenkrebs.
CA2601221C (en) * 2005-03-18 2013-08-06 The Chinese University Of Hong Kong A method for the detection of chromosomal aneuploidies
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
US20070087387A1 (en) * 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
US20080318264A1 (en) * 2005-09-09 2008-12-25 University Of Iowa Research Foundation Biomarkers Associated With Age-Related Macular Degeneration
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
US20070190580A1 (en) * 2005-10-31 2007-08-16 Beckman Coulter, Inc. Immunoassay of Fragments of Insulin-Like Growth Factor Binding Proteins
US7981399B2 (en) * 2006-01-09 2011-07-19 Mcgill University Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
WO2007089734A2 (en) * 2006-01-27 2007-08-09 Eastern Virginia Medical School Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
US7790463B2 (en) 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20090305259A1 (en) * 2006-03-21 2009-12-10 Yale University Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
EP2462945B1 (en) * 2006-08-16 2014-06-04 National Research Council of Canada Method of inhibiting angiogenesis, tumorigenesis and cathepsin activity
AU2007312960A1 (en) * 2006-10-20 2008-04-24 Newcastle Innovation Limited Assay for the detection of biomarkers associated with pregnancy related conditions
CA2673946C (en) * 2006-12-26 2014-10-14 Brigham Young University Serum proteomics system and associated methods
WO2008112424A1 (en) * 2007-03-08 2008-09-18 Mayo Foundation For Medical Education And Research Assessing heart failure
WO2008134881A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
CA2693098C (fr) 2007-07-19 2019-06-18 Yasemin Ataman-Onal Procede de dosage de la proteine de liaison hepatique aux acides gras, de l'antigene carcino-embryonnaire, et de l'antigene carbohydrate 19-9 pour le diagnostic in vitro du cancercolorectal
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
EP2179288A4 (en) * 2007-07-20 2010-07-21 Univ Utah Res Found IDENTIFYING AND QUANTIFYING BIOMARKERS TO EVALUATE THE RISK OF A BREAKFAST
WO2009046447A1 (en) * 2007-10-06 2009-04-09 Katalin Polgar Fetal open lesion detection system
US20100273666A1 (en) * 2007-12-13 2010-10-28 Bernatchez Stephanie F Methods of analyzing wound samples
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009097579A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US8481273B2 (en) * 2008-06-20 2013-07-09 University Of Delaware Perlecan fragments as biomarkers of bone stromal lysis
US20110247404A1 (en) * 2008-06-25 2011-10-13 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
US8476008B2 (en) 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
WO2011053832A1 (en) * 2009-10-29 2011-05-05 The Trustees Of Columbia University In The City Of New York Use of urinary ngal to diagnose sepsis in very low birth weight infants
CN102667486B (zh) 2009-11-25 2016-03-09 霍洛吉克股份有限公司 羊膜内感染的检测
AU2011226687A1 (en) 2010-03-11 2012-10-11 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
ES2667066T3 (es) 2010-05-24 2018-05-09 The Trustees Of Columbia University In The City Of New York Proteínas NGAL mutantes y usos de las mismas
CN103118698A (zh) * 2010-05-28 2013-05-22 意识-Nrg公司 神经调节素同种型，神经调节素多肽和其使用
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
WO2013016510A1 (en) * 2011-07-27 2013-01-31 Baylor College Of Medicine Process for preparing biological samples
JP6078067B2 (ja) 2011-08-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 炎症誘発性状態の治療および予防のためのｈｄｌ関連分子の使用
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
TW201425332A (zh) 2012-08-03 2014-07-01 Revo Biolog Inc 抗凝血酶用於體外膜氧合之用途
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
EP2925337B1 (en) 2012-11-21 2019-07-03 The Trustees of Columbia University in the City of New York Mutant ngal proteins and uses thereof
CN105008928A (zh) * 2012-12-20 2015-10-28 霍夫曼-拉罗奇有限公司 热稳定的dna聚合酶的表征
WO2014210031A1 (en) 2013-06-25 2014-12-31 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Proteomic biomarkers of sepsis in elderly patients
WO2017003954A1 (en) 2015-06-27 2017-01-05 Stimlabs Llc Products derived from amniotic fluid and methods of use
EP4530633A3 (en) 2017-08-18 2026-03-25 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
US20200264188A1 (en) 2017-09-13 2020-08-20 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
US20190224277A1 (en) * 2018-01-22 2019-07-25 CyPhi LLC Bio-mimetic formulation
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS
WO2025243332A1 (en) * 2024-05-24 2025-11-27 Intignus Biotech Private Limited Lfa device for detecting biomarkers for intrapartum and neonatal complications and method thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871937A (en) * 1985-04-30 1999-02-16 The Scripps Research Institute Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
JP2003517267A (ja) * 1998-02-25 2003-05-27 ナショナル・ユニバーシティ・オブ・アイルランド，コーク Ｈｌａ連鎖子癇前症および流産感受性遺伝子
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000039583A1 (en) * 1998-12-28 2000-07-06 Kabushiki Kaisya Advance System for identifying microorganism
AU3712200A (en) * 1999-03-01 2000-09-21 Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
WO2000060354A1 (en) * 1999-04-07 2000-10-12 Unilever Plc Lipopolysaccharide immunoassay and test device
AU6615500A (en) * 1999-07-28 2001-02-19 Genetics Institute Inc. Preventing immune-mediated abortion by inhibiting costimulation
US6653151B2 (en) * 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
JP2003515349A (ja) * 1999-11-30 2003-05-07 オクソ ヒェミー アーゲー 遺伝子発現の解析による臨床結果の評価および予測
WO2003075016A1 (en) * 2002-03-07 2003-09-12 Cambridge University Technical Services Limited (Cuts) Scd fingerprints
CN1395103A (zh) * 2002-07-31 2003-02-05 中华人民共和国北京出入境检验检疫局 疯牛病病原检测压电生物芯片及其制备方法
JP2006511790A (ja) 2002-11-14 2006-04-06 サイファージェン バイオシステムズ インコーポレイテッド 羊膜内炎症のためのバイオマーカー
AU2003290773A1 (en) * 2003-02-05 2004-09-06 Ciphergen Biosystems, Inc. Non-invasive assessment of intra-amniotic environment
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
US20060063162A1 (en) * 2004-09-23 2006-03-23 Deng David X Biological marker for inflammation
AU2005290314A1 (en) * 2004-09-28 2006-04-06 Singulex, Inc. System and method for spectroscopic analysis of single particles
GB0426982D0 (en) * 2004-12-09 2005-01-12 Secr Defence Early detection of sepsis
CA2605143A1 (en) * 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
US20070037224A1 (en) * 2005-08-11 2007-02-15 Hamer Peter J Quantitative assays for PDGFR-beta in body fluids
WO2007041623A2 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
WO2007047041A2 (en) * 2005-10-14 2007-04-26 Hyperion Biotechnology, Inc. Methods and compositions for biomarkers associated with change in physical performance
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20080031874A1 (en) * 2006-02-06 2008-02-07 Sanders Martin E Treatment of endotoxemia using endotoxin neutralizing agents
JP2009536641A (ja) * 2006-05-31 2009-10-15 ハンワ ケミカル コーポレイション Ｖｃａｍ−１特異的モノクローナル抗体
US20080199426A1 (en) * 2007-01-11 2008-08-21 Sukhatme Vikas P Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103415769A (zh) * 2010-12-06 2013-11-27 普罗诺塔股份有限公司 用于妊娠性高血压疾病的生物标志物和参数
CN103415769B (zh) * 2010-12-06 2017-04-12 迈卡蒂斯股份有限公司 用于妊娠性高血压疾病的生物标志物和参数
CN102426243A (zh) * 2011-11-17 2012-04-25 成都创宜生物科技有限公司 以Adipsin为检测指标的子痫前期检测试剂盒及制备方法
CN102426243B (zh) * 2011-11-17 2014-03-19 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期检测试剂盒的制备方法
CN105452868A (zh) * 2013-03-22 2016-03-30 曼普诊断有限公司 产前筛选
CN107850604A (zh) * 2015-05-12 2018-03-27 生物梅里埃公司 收入重症监护病房的患者发生播散性感染的风险预测
CN108450003A (zh) * 2015-06-19 2018-08-24 赛拉预测公司 用于预测早产的生物标志物对
CN105372414A (zh) * 2015-10-09 2016-03-02 成都大熊猫繁育研究基地 大熊猫乳汁中关键因子的分析方法
CN110366597A (zh) * 2016-12-20 2019-10-22 善威生物私人有限公司 用蛋白酶抑制剂进行血液图谱分析
US11693006B2 (en) 2016-12-20 2023-07-04 Sangui Bio Pty. Ltd Blood profiling with protease inhibitors
CN110366597B (zh) * 2016-12-20 2024-03-29 善威生物私人有限公司 用蛋白酶抑制剂进行血液图谱分析
CN113092771A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-1B-糖蛋白及其多肽片段在过敏性疾病中的应用
CN113092773A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-胰蛋白酶抑制剂重链H4及其多肽片段在过敏性疾病中的应用
WO2022027808A1 (zh) * 2020-08-05 2022-02-10 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用
CN120233090A (zh) * 2025-03-28 2025-07-01 中日友好医院(中日友好临床医学研究所) 一组尿蛋白标志物及其在制备非小细胞肺癌预后预测产品中的应用
CN120233090B (zh) * 2025-03-28 2025-09-09 中日友好医院(中日友好临床医学研究所) 一组尿蛋白标志物及其在制备非小细胞肺癌预后预测产品中的应用

Also Published As

Publication number Publication date
EP2088433A1 (en) 2009-08-12
US20090055099A1 (en) 2009-02-26
WO2004088324A3 (en) 2005-06-02
JP2006524331A (ja) 2006-10-26
EP1618388B1 (en) 2009-02-18
JP5011410B2 (ja) 2012-08-29
CA2560972A1 (en) 2004-10-14
US20040197930A1 (en) 2004-10-07
WO2004088324A2 (en) 2004-10-14
EP1618388A2 (en) 2006-01-25
DE602004019511D1 (de) 2009-04-02
MXPA05010325A (es) 2006-03-17
AU2004225527B2 (en) 2009-10-29
US20080299594A1 (en) 2008-12-04
JP2010122238A (ja) 2010-06-03
DK1618388T3 (da) 2009-05-18
ES2322593T3 (es) 2009-06-23
AU2010200352A1 (en) 2010-02-18
AU2004225527A1 (en) 2004-10-14
US7191068B2 (en) 2007-03-13
ATE423322T1 (de) 2009-03-15

Similar Documents

Publication Publication Date Title
CN1795387A (zh) 生物液体的蛋白质组分析
JP2006524331A5 (https=)
US10215760B2 (en) Detection of intraamniotic and/or infection
US20060094039A1 (en) Diagnosis of fetal aneuploidy
CN101611319A (zh) 对宫颈-阴道液体进行蛋白质组分析从而在怀孕雌体中检测宫内感染或确定早产危险
CN102334033A (zh) 生物学流体中供检测新生儿败血病用的生物标志
AU2016202346B2 (en) Secretome profile-facilitated in vitro fertilization
US20100017143A1 (en) Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
CN1610831A (zh) 通过检测肿瘤发生和转移相关蛋白的糖基化变化诊断癌症的方法及使用其诊断癌症的试剂盒
JP5924502B2 (ja) リンパ球性漏斗下垂体後葉炎のバイオマーカー及びその用途
JP2010507093A (ja) バイオマーカー
HK1093366A (en) Proteomic analysis of biological fluids
EP1914548A1 (en) Method for identifying women with an increased risk of preterm delivery
CN113325183B (zh) 一种用于鉴别诊断em/fem的试剂盒
EP4124864A1 (en) In vitro method for the prognosis of patients suffering from sepsis
HK1133922A (en) Proteomic analysis of biological fluids
CN114686582A (zh) Gdf15和itih3在孕早期自然流产预测中的应用
Kolla Identification of Screening Biomarkers for Chromosomal Anomalies and Pregnancy-related Disorder Using Quantitative Plasma Proteomics

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1093366

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060628

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1093366

Country of ref document: HK